Oxaliplatin induces ferroptosis and oxidative stress in HT29 colorectal cancer cells by inhibiting the Nrf2 signaling pathway

Oxaliplatin is a third-generation platinum drug that is used as first-line chemotherapy for colorectal cancer (CRC). Ferroptosis has been demonstrated to induce cell death and oxidative stress in CRC. The aim of the present study was to investigate whether oxaliplatin could exert anticancer effects...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Ben, Wang, Hui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047032/
https://www.ncbi.nlm.nih.gov/pubmed/35495610
http://dx.doi.org/10.3892/etm.2022.11321

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9047032/
https://www.ncbi.nlm.nih.gov/pubmed/35495610
http://dx.doi.org/10.3892/etm.2022.11321

Ejemplares similares